Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy.
Riesmeyer
Jeffrey S
JS
Reid
Philip R
PR
Miller
Debra L
DL
D003327:Coronary Disease / Q000150:complications* / Q000188:drug therapy*; D003627:Data Interpretation, Statistical; D048909:Diabetes Complications; D000077542:Eptifibatide; D006801:Humans; D010455:Peptides / Q000494:pharmacology / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D012107:Research Design / Q000592:standards*; D016896:Treatment Outcome
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077542:Eptifibatide